MSL
AVNS

Mackay Shields LLC’s Avanos Medical AVNS Stock Holding History

Mackay Shields LLC’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,700
Closed -$205K – 763
2021
Q1 		$205K Buy
+4,700
New +$221K ﹤0.01% 1409
2018
Q2 		– Sell
-23,564
Closed -$1.09M – 1205
2018
Q1 		$1.09M Buy
+23,564
New +$1.12M 0.01% 963

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Mackay Shields LLC's AVNS Position: Q2 2021 in Review

Mackay Shields LLC sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 4,700 shares — an estimated $205K sold.

Mackay Shields LLC first reported a position in AVNS in Q1 2018 and held it in 2 quarters. The position peaked at $1.09M in Q1 2018. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

  • Mackay Shields LLC reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 4,700 Avanos Medical shares in Q2 2021, an estimated $205K.
  • Mackay Shields LLC first reported a position in Avanos Medical in Q1 2018 and held it in 2 quarters.
  • Mackay Shields LLC's Avanos Medical position peaked at $1.09M in Q1 2018.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.